AVGR Stock Price, Chart, Stats & News

Avinger, Inc.
Save
1.52M
Market cap
–
Current P/E
–
Forward P/E
AVGR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 26.18% |
Operating margin | -217.39% |
Pretax margin | -239.41% |
Net margin | -239.41% |
Effective tax rate | – |
ROA | -133.04% |
ROE | 1782.10% |
D/E | -2.48x |
Interest coverage ratio | -9.68x |
AVGR valuation
P/E | – |
P/S | 0.20x |
P/B | -0.06x |
P/CF | -0.03x |
P/FCF | -0.10x |
P/OCF | -0.03x |
PEG | -0.00x |
EV multiple | 0.53x |
About
Avinger, Inc. is a commercial-stage medical technology firm that develops, manufactures, and markets sophisticated image-guided, catheter-based systems. These devices are utilized by physicians both domestically and internationally to treat patients suffering from Peripheral Arterial Disease (PAD). Central to Avinger's offerings is its proprietary lumivascular platform.
Similar securities
Based on sector and market capitalization
Report issue











